Delcath Systems Inc
NASDAQ:DCTH
Delcath Systems Inc
NASDAQ:DCTH
Price:
8.03 USD
6.08%
Updated:
May 21, 2024
EV/IC
Enterprise Value to IC
Enterprise Value to IC
23.6
Current
7.5
Median
2
Industry
Higher
than median
Higher
than industry value
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
EV/IC
=23.6
Enterprise Value
/
177.2m
Invested Capital
7.5m
All Countries
| Market Cap | EV/IC | ||||
|---|---|---|---|---|---|
| US |
|
Delcath Systems Inc
NASDAQ:DCTH
|
204.3m USD | 23.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
179.4B USD | 3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.6B USD | 12.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.9B USD | 3.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 1.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.7B USD | 3.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.7B USD | 1.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.6B EUR | 1.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54.4B USD | 7.6 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.8B USD | 15.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
369.4B CNY | 13.2 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/IC
N/A
2-Years Forward
EV/IC
N/A
3-Years Forward
EV/IC
N/A
You don't have any saved screeners yet
